Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant.
Mengarelli A, Annibali O, Pimpinelli F, Riva E, Gumenyuk S, Renzi D, Cerchiara E, Piccioni L, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Cordone I, Canfora M, Arcese W, Ensoli F, Marchesi F. Mengarelli A, et al. Among authors: palombi f. J Infect. 2016 Feb;72(2):265-8. doi: 10.1016/j.jinf.2015.11.005. Epub 2015 Dec 12. J Infect. 2016. PMID: 26687516 No abstract available.
Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study.
Marchesi F, Pimpinelli F, Dessanti ML, Gumenyuk S, Palombi F, Pisani F, Romano A, Spadea A, Maschio M, Ensoli F, Mengarelli A. Marchesi F, et al. Among authors: palombi f. Transpl Infect Dis. 2014 Dec;16(6):1032-8. doi: 10.1111/tid.12309. Epub 2014 Nov 5. Transpl Infect Dis. 2014. PMID: 25369809
Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network.
Marchesi F, Cerchiara E, Dessanti ML, Gumenyuk S, Franceschini L, Palombi F, Pisani F, Romano A, Spadea A, Pupo L, Annibali O, La Malfa A, Arcese W, Mengarelli A. Marchesi F, et al. Among authors: palombi f. Br J Haematol. 2015 Apr;169(2):293-6. doi: 10.1111/bjh.13199. Epub 2014 Nov 5. Br J Haematol. 2015. PMID: 25371286 Free article. No abstract available.
Flow cytometry characterization in central nervous system and pleural effusion multiple myeloma infiltration: an Italian national cancer institute experience.
Marchesi F, Masi S, Summa V, Gumenyuk S, Merola R, Orlandi G, Cigliana G, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, De Bellis F, Conti L, Mengarelli A, Cordone I. Marchesi F, et al. Among authors: palombi f. Br J Haematol. 2016 Mar;172(6):980-2. doi: 10.1111/bjh.13549. Epub 2015 Jun 17. Br J Haematol. 2016. PMID: 26081466 Free article. No abstract available.
Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience.
Marchesi F, Vacca M, Gumenyuk S, Pandolfi A, Renzi D, Palombi F, Pisani F, Romano A, Spadea A, Ipsevich F, Santinelli S, De Rienzo M, Papa E, Canfora M, Laurenzi L, Foddai ML, Pierelli L, Mengarelli A. Marchesi F, et al. Among authors: palombi f. Leuk Lymphoma. 2016 Feb;57(2):489-492. doi: 10.3109/10428194.2015.1063147. Epub 2015 Jul 18. Leuk Lymphoma. 2016. PMID: 26099572 No abstract available.
Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study.
Cordone I, Marchesi F, Masi S, Summa V, Pisani F, Merola R, Cigliana G, Orlandi G, Gumenyuk S, Palombi F, Romano A, Spadea A, Renzi D, Papa E, Canfora M, Conti L, Petti MC, Mengarelli A. Cordone I, et al. Among authors: palombi f. J Exp Clin Cancer Res. 2016 Mar 19;35:49. doi: 10.1186/s13046-016-0324-0. J Exp Clin Cancer Res. 2016. PMID: 26992692 Free PMC article.
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study.
Marchesi F, Tendas A, Giannarelli D, Viggiani C, Gumenyuk S, Renzi D, Franceschini L, Caffarella G, Rizzo M, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Pignatelli A, Cantonetti M, Arcese W, Mengarelli A. Marchesi F, et al. Among authors: palombi f. Bone Marrow Transplant. 2017 Jan;52(1):154-156. doi: 10.1038/bmt.2016.207. Epub 2016 Aug 15. Bone Marrow Transplant. 2017. PMID: 27526285 Clinical Trial. No abstract available.
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant.
Renzi D, Marchesi F, De Angelis G, Elia L, Salvatorelli E, Gumenyuk S, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Arcese W, Mengarelli A; Rome Transplant Network. Renzi D, et al. Among authors: palombi f. Chemotherapy. 2017;62(1):58-61. doi: 10.1159/000448750. Epub 2016 Sep 10. Chemotherapy. 2017. PMID: 27618144 Free article.
The predictive value of Aspergillus PCR testing on bronchoalveolar lavage fluid for early diagnosis of invasive pulmonary aspergillosis in hematologic patients.
Marchesi F, Spadea A, Pimpinelli F, Prignano G, Paglia MG, Forcella D, Gumenyuk S, Renzi D, Palombi F, Vulcano A, Pisani F, Romano A, Papa E, Facciolo F, Ensoli F, Girmenia C, Mengarelli A. Marchesi F, et al. Among authors: palombi f. Leuk Lymphoma. 2017 Dec;58(12):2943-2946. doi: 10.1080/10428194.2017.1315116. Epub 2017 May 9. Leuk Lymphoma. 2017. PMID: 28482726 No abstract available.
83 results